Bensen Daniel 4
4 · Tyra Biosciences, Inc. · Filed Nov 19, 2025
Insider Transaction Report
Form 4
Bensen Daniel
Chief Discovery Officer
Transactions
- Sale
Common Stock
2025-11-18$16.07/sh−75,633$1,215,627→ 220,937 total - Sale
Common Stock
2025-11-19$16.32/sh−49,956$815,297→ 170,981 total
Footnotes (3)
- [F1]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 5, 2024.
- [F2]Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $16.00 to $16.24. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
- [F3]Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $16.04 to $16.68. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.